文献速递心脏核医学

慢性冠脉综合征中¹³N-氨PET心肌血流储备降低与心衰相关风险独立于相对缺血

Reduced ¹³N-Ammonia PET Myocardial Flow Reserve and Heart-Failure-Related Risk Independent of Relative Ischemia in Chronic Coronary Syndrome.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-09-16

本研究回顾性分析168例慢性冠脉综合征患者,评估未校正整体心肌血流储备(MFR)低于2.0对硬终点(死亡、心梗、心衰住院或恶性室性心律失常)的预后价值。中位3.5年随访中,MFR低于2.0组事件发生率27.5% vs 7.6%,校正相对缺血后仍独立相关(HR 4.5182)。RPP校正重分类52例(31.0%),支持报告未校正MFR并明确标注校正值。

要点

  • 未校正整体MFR低于2.0独立于相对缺血预测硬终点(HR 4.5182)。
  • MFR低于2.0组事件率27.5%,显著高于MFR≥2.0组的7.6%。
  • RPP校正重分类52例(31.0%),多向下重分类,支持报告未校正值。

核心结论

  • 未校正整体MFR低于2.0可识别慢性冠脉综合征高风险患者,独立于相对缺血,包括无基线心衰者。
  • RPP校正重分类43例低于阈值,支持报告未校正储备并明确标注校正值。

研究设计与样本

  • 单中心回顾性研究,连续纳入疑似或确诊慢性冠脉综合征行¹³N-氨PET/CT的成人168例。
  • 主要暴露为未校正整体MFR低于2.0,同时报告RPP校正MFR。
  • 主要终点为硬性非血运重建复合终点:死亡、非致死性心梗、心衰住院或恶性室性心律失常。
  • 预设Cox模型按扫描仪代次分层,校正年龄、性别和总和差值评分。

主要发现

  • 168例中102例(60.7%)MFR低于2.0,其静息血流更高、负荷血流更低(P=0.001和P<0.001)。
  • 中位3.5年随访,MFR低于2.0组终点事件28/102(27.5%),MFR≥2.0组5/66(7.6%),log-rank P<0.001。
  • 主要模型中MFR低于2.0与终点独立相关(HR 4.5182,95%CI 1.7121-11.9236,P=0.002)。
  • 排除基线心衰后仍独立相关(HR 4.1693,P=0.011)。
  • RPP校正重分类52例(31.0%),多向下重分类;向下重分类后事件率7.0%,双值均受损者事件率29.0%(四组log-rank P=0.003)。

关键数值与推荐

  • 未校正整体MFR低于2.0为高风险阈值。
  • RPP校正重分类52例(31.0%),其中43例低于阈值。
  • 主要模型HR 4.5182(95%CI 1.7121-11.9236,P=0.002);排除基线心衰后HR 4.1693(P=0.011)。

临床怎么用

  • 在慢性冠脉综合征PET评估中,应报告未校正整体MFR,并明确标注RPP校正值。
  • 未校正MFR低于2.0提示心衰相关硬终点风险升高,独立于相对缺血。

局限性

  • 单中心回顾性研究,样本量168例,结论需外部验证。
  • RPP校正重分类比例较高(31.0%),校正方法对风险分层的影响需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study evaluated whether uncorrected global myocardial flow reserve (MFR) below 2.0 on ¹³N-ammonia PET stratified risk in chronic coronary syndrome (CCS), and how rate-pressure-product (RPP) correction reclassified patients. METHODS: Consecutive adults with suspected or established CCS undergoing ¹³N-ammonia PET/CT at a single Japanese center were retrospectively studied. Uncorrected global MFR below 2.0 was the primary exposure, with RPP-corrected MFR reported alongside. The primary endpoint was a hard non-revascularization composite of death, non-fatal myocardial infarction, heart-failure hospitalization, or malignant ventricular arrhythmia. The pre-specified Cox model, stratified by scanner generation, adjusted for age, sex, and summed difference score. RESULTS: Of 168 patients, 102 (60.7%) had MFR below 2.0, with higher rest and lower stress flow (P = 0.001 and P < 0.001). Over a median 3.5 years, the endpoint occurred in 28 of 102 (27.5%) versus 5 of 66 (7.6%; log-rank P < 0.001). In the primary model, MFR below 2.0 remained independently associated with the endpoint (hazard ratio 4.5182, 95% CI 1.7121-11.9236, P = 0.002), and after excluding baseline heart failure (4.1693, P = 0.011). RPP correction reclassified 52 patients (31.0%), mostly downward. Event rates were 7.0% after downward reclassification and 29.0% in patients impaired on both values (four-group log-rank P = 0.003). CONCLUSION: Uncorrected global MFR below 2.0 identified higher-risk patients with CCS independently of relative ischemia, including those without baseline heart failure. RPP correction reclassified 43 patients below the threshold, supporting reporting of the uncorrected reserve with explicit labeling of any corrected value.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Fukushima Y, Kobayashi R, Yodogawa K, et al. Reduced ¹³N-Ammonia PET Myocardial Flow Reserve and Heart-Failure-Related Risk Independent of Relative Ischemia in Chronic Coronary Syndrome. Eur J Nucl Med Mol Imaging. 2026. PMID: 42747488. doi:10.1007/s00259-026-08183-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。